Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,709 | 3,326 | 3,502 | 2,594 | 2,597 |
| Receivables | N/A | 800 | N/A | N/A | N/A |
| TOTAL | $3,725 | $4,161 | $3,594 | $2,672 | $2,625 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $3,725 | $4,161 | $3,594 | $2,672 | $2,625 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,420 | 1,329 | 1,261 | 800 | 944 |
| Other current liabilities | 2 | N/A | 1 | 16 | 29 |
| TOTAL | $1,422 | $1,329 | $1,262 | $816 | $973 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 9 | 6 | 6 | 15 | 11 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,422 | $1,329 | $1,262 | $816 | $973 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,184 | 3,184 | 3,184 | 3,150 | 1,912 |
| Retained earnings | -104,780 | -104,097 | -104,432 | -102,580 | -101,036 |
| Other shareholders' equity | -1,254 | -1,226 | -1,178 | -941 | -958 |
| TOTAL | $2,303 | $2,832 | $2,332 | $1,856 | $1,652 |
| Total Liabilities And Equity | $3,725 | $4,161 | $3,594 | $2,672 | $2,625 |